Christopher Chapron
Impact in
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- HIV/AIDS drug development and treatment 4
- Viral gastroenteritis research and epidemiology 2
-
- Hepatitis B Virus Studies 2
- Cytomegalovirus and herpesvirus research 1
- Co-authors
- Aaron B. Margolin (2 shared papers)Justin H. Fontaine (1 shared paper)Maria Seifer (5 shared papers)David N. Standring (3 shared papers)Massimiliano La Colla (4 shared papers)Joseph McCarville (3 shared papers)John P. Bilello (2 shared papers)Claire Pierra (2 shared papers)
- Journals
- Journal of Hepatology (3 papers)Applied and Environmental Microbiology (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Journal of Applied Microbiology (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Christopher Chapron
8 papers receiving 245 citations
Peers
Comparison fields: 5 of 45
- Infectious Diseases 184
- Hepatology 52
- Animal Science and Zoology 34
- Water Science and Technology 41
- Cardiology and Cardiovascular Medicine 43
Countries citing papers authored by Christopher Chapron
This map shows the geographic impact of Christopher Chapron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Chapron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Chapron more than expected).
Fields of papers citing papers by Christopher Chapron
This network shows the impact of papers produced by Christopher Chapron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Chapron. The network helps show where Christopher Chapron may publish in the future.
Co-authors
The 23 scholars most cited alongside Christopher Chapron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 186 | |
| 2 | 2014 | 23 | |
| 3 | 2006 | 17 | |
| 4 | 2000 | 16 | |
| 5 | 2014 | 10 | |
| 6 | 2011 | 7 | |
| 7 | 2014 | 3 | |
| 8 | 2024 | 1 |
About Christopher Chapron
Christopher Chapron is a scholar working on Infectious Diseases, Epidemiology, Hepatology, Genetics and Immunology, having authored 8 papers that have together received 263 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (4 papers), Hepatitis C virus research (3 papers), Viral gastroenteritis research and epidemiology (2 papers), Virus-based gene therapy research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Hepatitis B Virus Studies (2 papers), Regulation of Appetite and Obesity (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Infectious Diseases (184 citations), Hepatology (52 citations), Animal Science and Zoology (34 citations), Water Science and Technology (41 citations) and Cardiology and Cardiovascular Medicine (43 citations). Christopher Chapron has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Aaron B. Margolin, Justin H. Fontaine, Maria Seifer, David N. Standring, Massimiliano La Colla, Joseph McCarville, John P. Bilello, Claire Pierra, Ilaria Serra and George Chao. Their work appears in journals such as Journal of Hepatology, Applied and Environmental Microbiology, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters and Journal of Applied Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.